The impact of dose-escalated RT on ADT in patients with intermediate risk prostate cancer

被引：0
|
作者：
Onal, Cem [1 ,2 ]
Guler, Ozan Cem [1 ]
Erbay, Gurcan [3 ]
Elmali, Aysenur [2 ]
机构：
[1] Baskent Univ, Dept Radiat Oncol, Fac Med, Adana, Turkiye
[2] Baskent Univ, Dept Radiat Oncol, Fac Med, Ankara, Turkiye
[3] Baskent Univ, Dept Radiol, Fac Med, Adana, Turkiye
来源：
RADIOTHERAPY AND ONCOLOGY | 2024年 / 194卷
关键词：
ADT; Prostate cancer; Radiotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
126
引用
收藏
页码：S2293 / S2294
页数：2
相关论文
共 50 条
  • [21] Clinical Outcomes of Dose-escalated Radiotherapy for Localised Prostate Cancer: A Single-institution Experience
    Meng, Katherine
    Lim, Keith
    Lee, Chia Ching
    Chia, David
    Ooi, Kiat Huat
    Soon, Yu Yang
    Tey, Jeremy
    IN VIVO, 2020, 34 (02): : 757 - 765
  • [22] The role of the maximum involvement of biopsy core in predicting outcome for patients treated with dose-escalated radiation therapy for prostate cancer
    Jure Murgic
    Matthew H Stenmark
    Schuyler Halverson
    Kevin Blas
    Felix Y Feng
    Daniel A Hamstra
    Radiation Oncology, 7
  • [23] Decision Regret in Men Undergoing Dose-Escalated Radiation Therapy for Prostate Cancer
    Steer, Anna N.
    Aherne, Noel J.
    Gorzynska, Karen
    Hoffman, Matthew
    Last, Andrew
    Hill, Jacques
    Shakespeare, Thomas P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 86 (04): : 716 - 720
  • [24] Dose-escalated robotic SBRT for stage I-II prostate cancer
    Meier, Robert
    FRONTIERS IN ONCOLOGY, 2015, 5
  • [25] Survival Outcomes of Dose-Escalated External Beam Radiotherapy versus Combined Brachytherapy for Intermediate and High Risk Prostate Cancer Using the National Cancer Data Base
    Amini, Arya
    Jones, Bernard
    Jackson, Matthew W.
    Yeh, Norman
    Waxweiler, Timothy V.
    Maroni, Paul
    Kavanagh, Brian D.
    Raben, David
    JOURNAL OF UROLOGY, 2016, 195 (05) : 1453 - 1458
  • [26] Dose-escalated simultaneous integrated-boost treatment of prostate cancer patients via helical tomotherapy
    Geier, M.
    Astner, S. T.
    Duma, M. N.
    Jacob, V.
    Nieder, C.
    Putzhammer, J.
    Winkler, C.
    Molls, M.
    Geinitz, H.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 (05) : 410 - 416
  • [27] Causes of Mortality After Dose-Escalated Radiation Therapy and Androgen Deprivation for High-Risk Prostate Cancer
    Tendulkar, Rahul D.
    Hunter, Grant K.
    Reddy, Chandana A.
    Stephans, Kevin L.
    Ciezki, Jay P.
    Abdel-Wahab, May
    Stephenson, Andrew J.
    Klein, Eric A.
    Mahadevan, Arul
    Kupelian, Patrick A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (01): : 94 - 99
  • [28] MRI-guided Dose-escalated Salvage Radiotherapy for Bulky Bladder Neck Recurrence of Prostate Cancer
    Kishan, Amar U.
    Tyran, Marguerite
    Steinberg, Michael L.
    Holden, Stuart B.
    Cao, Minsong
    CUREUS, 2018, 10 (03):
  • [29] Dose-escalated abarelix in androgen-independent prostate cancer: a phase I study
    Beer, Tomasz M.
    Ryan, Christopher
    Bhat, Gajanan
    Garnick, Marc
    ANTI-CANCER DRUGS, 2006, 17 (09) : 1075 - 1079
  • [30] Long-Term Outcomes of Dose-Escalated Hypofractionated Radiotherapy in Localized Prostate Cancer
    Lazo, Antonio
    de la Torre-Luque, Alejandro
    Arregui, Gregorio
    Rivas, Daniel
    Serradilla, Ana
    Gomez, Joaquin
    Jurado, Francisca
    Isabel Nunez, Maria
    Lopez, Escarlata
    BIOLOGY-BASEL, 2022, 11 (03):
12345